CCNE2 and hepatocellular carcinoma: Honokiol regulates the expression level of cyclin-dependent kinase Cyclin E2 (CCNE2) via stimulating the deacylation activity of SIRT3, which leads to the inhibition of the progression of hepatocellular carcinoma (HCC) 69.